Published in Dermatol Monatsschr on May 01, 1971
[Hyperinsulinism and limited glucose-tolerance in psoriasis]. Arch Dermatol Forsch (1972) 0.85
[Systemic effects of ultraviolet, visible and infrared radiation in serial whole body irradiation. I. Oxygen utilization, flow properties of blood, hemodynamics, blood components and phagocytosis]. Dermatol Monatsschr (1989) 1.40
[Determination of the antinuclear factors in lupus erythematosus]. Dermatol Wochenschr (1965) 1.06
[On the behavior of glucose-6-phosphate dehydrogenase in the serum and erythrocytes of subjects with psoriasis]. Arch Klin Exp Dermatol (1967) 0.97
[Photochemotherapy of psoriasis using 8-methoxypsoralen and UVA. II. Binding of the photosensitizator to protein]. Dermatol Monatsschr (1976) 0.93
[Characteristics of psoriasis in childhood]. Dermatol Monatsschr (1979) 0.92
[Antinuclear factors in psoriasis vulgaris. (Preliminary report)]. Dermatol Wochenschr (1965) 0.91
[Pathogenesis and nosologic status of psoriatic arthropathy]. Hautarzt (1971) 0.89
[Immunologic and clinical studies on psoriasis]. Dtsch Gesundheitsw (1966) 0.89
Stable lipid peroxidation products in human skin: detection, ultraviolet light-induced increase, pathogenic importance. Experientia (1976) 0.88
[Photochemotherapy with 8-methoxypsoralen and UVA. III. Fluorescent microscopy studies of binding and transport of 8-MOP in the human skin]. Dermatol Monatsschr (1977) 0.87
High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol (1998) 0.86
Anti-endothelial antibodies in Takayasu arteritis. Arthritis Rheum (1994) 0.85
[Studies on the excretion of tryptophan metabolites in patients with circumscript and progressive scleroderma]. Dermatol Wochenschr (1968) 0.85
[Electron microscopy studies in lichen sclerosus and antrophicus]. Dermatol Monatsschr (1972) 0.85
[Abnormal HLA-DR antigen expression in monocytes of patients with systemic lupus erythematosus and psoriasis vulgaris]. Dermatol Monatsschr (1985) 0.84
[The lymphocyte transformation test in squamous epithelial carcinomas of the orofacial region]. Zahn Mund Kieferheilkd Zentralbl (1977) 0.82
[Selected ultraviolet phototherapy (SUP) with fluorescent bulbs in psoriasis vulgaris. II. Effect on immune complexes, DNA antibodies and T cells in vivo]. Dermatol Monatsschr (1983) 0.82
[The pathogenetic significance of "autoantibodies" in the NZB-W-F1 hybrids. II. Morphological studies]. Acta Biol Med Ger (1973) 0.82
Effect of splenopentin (SP-5) on the antibody formation in immunosuppressed mice. Exp Clin Endocrinol (1986) 0.81
[Studies on the pathogenesis of acrodermatitis enteropathica Danbolt-Closs]. Arch Klin Exp Dermatol (1967) 0.81
[Lymphocyte transformation test in bullous dermatoses]. Dermatol Monatsschr (1977) 0.81
[Clinical and physiopathological findings in lichen sclerosus et atrophicus]. Arch Klin Exp Dermatol (1968) 0.81
Detection of interferon in the sera of patients with psoriasis, and its enhancement by PUVA treatment. Br J Dermatol (1983) 0.80
[Clinical manifestations and diagnosis of penicillin allergy and other penicillin side effects]. Dermatol Monatsschr (1969) 0.80
The influence of topical dermatological treatment modalities on epidermal Langerhans cells and contact sensitization in mice. Contact Dermatitis (1992) 0.80
[Immunological studies on the nosology of psoriasis arthropathica]. Allerg Asthma (Leipz) (1969) 0.80
[On the evidence of antinuclear factors in various forms fof psoriasis]. Arch Klin Exp Dermatol (1966) 0.79
[Epilepsy as an early symptom of lupus erythematosus]. Dermatol Wochenschr (1965) 0.79
[Differentiation of the antipsoriatic and phototoxic effectiveness of topical PUVA therapy]. Hautarzt (1986) 0.79
[Transitory acantholytic dermatosis (Grover) in an HIV infected patient]. Z Hautkr (1990) 0.79
[Stabilization of the erythrocyte membrane with UVA-irradiation using 8-methoxypsoralen]. Dermatol Monatsschr (1980) 0.79
Polyclonal B cell activation in the acute phase of systemic lupus erythematosus--aspects of pathogenic significance. J Invest Dermatol (1982) 0.78
[Liver involvement in erythropoietic protoporphyria]. Dermatol Monatsschr (1974) 0.78
[Inactivation and protection of phosphofructokinase during 8-methoxypsoralen and UVA-treatment]. Dermatol Monatsschr (1980) 0.78
[Destruction of peripheral lymphocytes by 8-MOP and UVA]. Dermatol Monatsschr (1980) 0.78
[On the problem of demonstration of antinuclear factors in scleroderma patients]. Dermatol Wochenschr (1966) 0.77
[Familial studies in lupus erythematosus]. Dermatol Wochenschr (1965) 0.77
[Recent studies on antinuclear factors with special reference to differential diagnostic and genetic viewpoints]. Z Gesamte Inn Med (1967) 0.77
Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma). J Rheumatol (1995) 0.77
[Comparative studies of senstive chronaxy in various forms of scleroderma and lichen sclerosus et atrophicus]. Dermatol Wochenschr (1968) 0.77
Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness. Skin Pharmacol (1994) 0.77
Studies on the effects of a high dose UVA-1 radiation therapy on surface markers and function of epidermal Langerhans cells. Arch Dermatol Res (1993) 0.76
[Differential diagnostic studies on lupus erythematosus chronicus discoides and lymphocyte infiltration Jessner-Kanof using the immunofluorescent technic]. Arch Klin Exp Dermatol (1968) 0.76
[Electron microscopy studies on the demonstration of virus-like particles in dermatomyositis]. Dermatol Monatsschr (1973) 0.76
[Electron microscopy studies of the muscles in lupus erythematosus]. Dermatol Monatsschr (1973) 0.76
The influence of interferon-gamma, interleukin-2, prostaglandin E2, and cyclosporine on the polyclonal and anti-DNA antibody secretion in lymphocyte cultures derived from patients with systemic lupus erythematosus. Arch Dermatol Res (1987) 0.76
Cis-urocanic acid as a mediator of ultraviolet-light-induced immunosuppression. Semin Hematol (1992) 0.76
[The role of immunofluorescence methods in dermatology (technic and clinical use)]. Dermatol Monatsschr (1970) 0.76
Stimulation of the recruitment of epidermal Langerhans cells by splenopentin. Arch Dermatol Res (1990) 0.75
[Treatment of arthropathic psoriasis with antimetabolites and glucocorticoids]. Dermatol Monatsschr (1971) 0.75
[Allergic diseases of the skin]. Z Arztl Fortbild (Jena) (1971) 0.75
[Behavior of leukocytes and antileukocytic antibodies in lupus erythematosus]. Dermatol Wochenschr (1967) 0.75
[Studies of muscle changes in chronic lupus erythematosus]. Arch Klin Exp Dermatol (1967) 0.75
[Studies on animal experiment models for the demonstration of sensitization potency of chemical combinations. II. Results after sensitization with cobalt chloride]. Dermatol Monatsschr (1973) 0.75
[Virus-like structures in the skin and kidneys of patients with chronic and visceral lupus erythematosus. Electron microscope study]. Vestn Dermatol Venerol (1974) 0.75
[Morphological and biochemical findings in multiple nevoxanthoendothelioma]. Hautarzt (1967) 0.75
[On the pathogenesis of medicamentous exanthema]. Z Arztl Fortbild (Jena) (1967) 0.75
[Drug sensitization in lupus erythematosus patients]. Allerg Asthma (Leipz) (1967) 0.75
[Tryptophan and tyrosine administration in acrodermatitis enteropathica (Danbolt)]. Klin Wochenschr (1967) 0.75
[Present knowledge on the pathogenesis of common psoriasis as the basis for a scientifically founded therapy. I. Pathogenesis of common psoriasis]. Dtsch Gesundheitsw (1970) 0.75
[Muscle lipids in dermatomyositis, progressive scleroderma, allergic subsepsis, impetigo herpetiformis, chronic lupus erythematosus and psoriasis vulgaris]. Dermatol Monatsschr (1973) 0.75
[Basic principles of autoimmune diseases]. Dermatol Monatsschr (1969) 0.75
[Studies on the currently increased incidence and on the clinical aspects and therapy of scabies]. Dtsch Gesundheitsw (1970) 0.75
[Clinical and morphologic peculiarities in simultaneous occurrence of lupus erythematodes and exanthema from drugs]. Z Haut Geschlechtskr (1966) 0.75
[Studies on the demonstration and the transferability of cellular antibodies in drug-induced exanthema]. Dermatol Wochenschr (1967) 0.75
[Characteristics of an uniform definition and nomenclature of the eczema-group]. Dermatol Monatsschr (1973) 0.75
[The problems of autoimmunization as basis of the so-called collagenoses]. Z Gesamte Inn Med (1969) 0.75
[Current knowledge on the pathogenesis of common psoriasis as the basis for a scientifically founded therapy. II. Therapeutic possibilities and pathogenetic principles of antipsoriatic drugs]. Dtsch Gesundheitsw (1970) 0.75
[On the question of autoimmunization as the basis of the so-called collagenoses]. Z Gesamte Inn Med (1969) 0.75
[Lupus erythematodes in childhood--a virus-induced autoimmune disease?]. Padiatr Grenzgeb (1974) 0.75
[Current viewpoints on the pathogenesis of lupus erythematosus]. Z Arztl Fortbild (Jena) (1971) 0.75
[Studies on the increase of scabies. II. Clinical aspects and epidemiology of the current scabies epidemics]. Dermatol Monatsschr (1971) 0.75
[Comparative infrared determinations of the rewarming of the skin in endogenous and atopic eczema]. Dermatol Monatsschr (1971) 0.75
[External therapy at the Hospital for Dermatology in Berlin]. Dermatol Monatsschr (1974) 0.75
[Significance of scabies in childhood]. Padiatr Grenzgeb (1974) 0.75
[On the diagnosis of dermatomyositis]. Dtsch Gesundheitsw (1966) 0.75
[Evaluation of serologic methods for the determination of antinuclear factors and their differential-diagnostic significance]. Dtsch Gesundheitsw (1967) 0.75
[Comprehensibility of latent muscle participation in lupus erythematodes]. Dermatol Monatsschr (1974) 0.75
[Therapeutic possibilities in chronic connective tissue diseases in ambulatory and stationary care]. Dermatol Wochenschr (1967) 0.75
[75th birthday of Professor Dr. Dr. h. c. Karl Linser]. Przegl Dermatol (1971) 0.75
[Drug hypersensitivity in lupus erythematosus]. Allerg Asthma (Leipz) (1967) 0.75
[Studies on the kidney involvement in lupus erythematodes chronicus]. Dermatol Monatsschr (1970) 0.75
[Current penicillin therapy of syphilis from a critical viewpoint]. Z Arztl Fortbild (Jena) (1971) 0.75
[Photometric demonstration of antibodies against deoxyribonucleic acid using the Farr technic]. Dermatol Monatsschr (1974) 0.75
[Current smallpox problems for the dermatologist]. Dermatol Monatsschr (1974) 0.75
[Rewarming, heat conduction ability and blood circulation of the skin in healthy subjects and scleroderma patients]. Dermatol Monatsschr (1974) 0.75
[Measurement of skin temperature with the infra-red radiation measuring device by Kortum]. Dermatol Monatsschr (1969) 0.75
[Animal experiment studies on the determination of sensitivity capacity of chemical compounds. 3. Results following sensitization with dinitrochlorobenzene and final evaluation]. Dermatol Monatsschr (1974) 0.75
[Indications and contraindications for the interruption in dermatologic diseases (author's transl)]. Ther Umsch (1974) 0.75
[Experiences with combined long term therapy of psoriasis arthropathica using antimetabolites and steroids]. Dermatol Monatsschr (1974) 0.75
[Impairment of DNA repair in xeroderma pigmentosa]. Dermatol Monatsschr (1973) 0.75
[Comparative immunological studies in lupus erythematosus, primary chronic polyarthritis and psoriasis arthropathica]. Allerg Asthma (Leipz) (1969) 0.75
[Autoimmunology studies in psoriasis patients]. Dermatol Monatsschr (1969) 0.75
[Diagnostic criteria in lupus erythematosus with special reference to skin changes]. Dermatol Monatsschr (1971) 0.75
[Comparative studies of the diagnostic usefulness of the intracutaneous leukocyte test and antinuclear factors in chronic lupus erythematosus]. Z Haut Geschlechtskr (1967) 0.75
[Present tasks and problems in the research of psoriasis]. Dermatol Monatsschr (1970) 0.75
[Is the post-therapeutic provocation test in gonorrhea justified?]. Dermatol Monatsschr (1973) 0.75
[Therapy of lupus erythematosus during pregnancy]. Dtsch Gesundheitsw (1969) 0.75
[The pathogenic significance of "autoantibodies" in NZB-W-F1 hybrids. 3. Immunohistological studies]. Acta Biol Med Ger (1973) 0.75
[Electron microscopic study of the bone marrow in chronic discoid and systemic lupus erythematosus]. Dermatol Monatsschr (1974) 0.75